Frequently Asked Questions

Barekyne is India's premium clinical derma skincare brand operating on a B2B franchise model. We manufacture and distribute a focused 5-SKU clinical skincare ecosystem engineered specifically for melanin-rich Indian skin (Fitzpatrick Scale IV-VI). We partner with pharmaceutical distributors, medical representatives, pharmacies, and dermatology clinics through our Exclusive District-Level Monopoly PCD Franchise model. We are WHO-GMP certified, ISO 9001:2015 certified, and CDSCO approved.

Barekyne is headquartered at 471, Sector 17 HUDA, Jagadhri, Yamunanagar, Haryana 135001, India. Our B2B operations serve franchise partners PAN-India across 15+ major cities. You can reach us at +91 70275 72757 or info@barekyne.in.

Barekyne products are manufactured in facilities holding WHO-GMP (World Health Organization Good Manufacturing Practices) certification, ISO 9001:2015 certification, and full CDSCO (Central Drugs Standard Control Organisation) approval. These are prominent, internationally recognized certifications — not limited certifications. This ensures pharmaceutical-grade consistency in every product batch.

PCD stands for Propaganda Cum Distribution. A Derma PCD Franchise gives you the exclusive right to distribute a pharmaceutical company's dermatological products in a designated territory. Barekyne's model grants you 100% district-level monopoly rights — meaning no other distributor can sell Barekyne products in your allocated district. You purchase initial inventory from us directly and then sell it to pharmacies, doctors, and clinics in your area at full MRP, earning the difference as your net margin.

The minimum investment to start a Barekyne PCD franchise is INR 50,000. This amount goes entirely into your initial product inventory. There are ZERO franchise fees, zero royalty charges, and zero security deposits. You pay only for the product stock you receive.

Barekyne distributors earn industry-leading net margins through our direct-from-manufacturer pricing model. Because we eliminate the middleman hierarchy (C&F agents, super stockists), the margin passed on to our franchise partners is significantly higher than the 15-25% standard offered by general PCD pharma competitors like Vindcare, Intra Life, or Scot Derma.

Barekyne grants legally binding, exclusive territorial distribution rights at the district level. This is documented in your partnership agreement. No other distributor will be authorized to sell Barekyne products to pharmacies, clinics, or hospitals within your allocated territory. This guarantees zero internal brand competition, stable pricing, and maximum capture of local market share.

Barekyne is currently in an exclusive Early Access launch phase, accepting applications for district-level franchise rights before the full public launch. High-demand territories across Tier 1 and Tier 2 cities are being locked in daily. Once a district is allocated, it is permanently removed from the available pool. To apply, visit barekyne.in/early-access and submit your details. Our team will respond within 24 hours.

Partners can begin with just a GSTIN for cosmetic-notified products like sunscreens, face washes, and lotions. A Wholesale Drug License (Form 20B/21B) is only required for Schedule H or prescription-category products. Our team will guide you through the exact documentation required for your specific product selection and state.

Every Barekyne franchise partner receives a complete marketing toolkit including: dermatologist-approved visual aids and detailing brochures, prescription pads with your contact information, patient education leaflets, point-of-sale display materials, digital marketing templates, territory-specific marketing strategy, and scientific ingredient documentation for doctor detailing. Our B2B team is available for ongoing support.

Barekyne's clinical ecosystem consists of 5 high-prescription SKUs: (1) Bare-UV Sunscreen — SPF 50 PA++++ hybrid invisible shield with Zinc PCA and Kakadu Plum, ₹649/50g. (2) Bare-C20 Serum — 20% Ethyl Ascorbic Acid multi-pathway brightening serum, ₹990/30ml. (3) Bare Night Cream — Kojic Acid Dipalmitate + Alpha Arbutin triple-pathway overnight depigmentation, ₹499/50g. (4) Cicaglow Facewash — barrier-first multi-acid cleanser with Polyglutamic Acid paradoxical hydration, ₹549/100ml. (5) Bare-Hydra Lotion — 90% melanin inhibition body brightening lotion, ₹499/200ml.

L-Ascorbic Acid is highly unstable in India's hot and humid climate. It oxidizes rapidly, turning yellow then orange then brown, losing all efficacy. It also requires a low pH of 2.5–3.5 which causes irritation on Indian skin. Barekyne uses 20% Ethyl Ascorbic Acid (3-O-Ethyl Ascorbic Acid), which is stable across pH 4.0–6.0, never yellows, and is compatible with Niacinamide. It delivers identical clinical efficacy via cellular esterase conversion — but without the climate-instability problems.

White cast is the visible white/grey residue left on the skin after applying traditional sunscreens — a major problem for melanin-rich skin (Fitzpatrick IV-VI) because it looks ashy and unnatural. Barekyne's Bare-UV sunscreen uses a dual physical-chemical filter matrix engineered to leave absolutely zero visible white cast, making it cosmetically elegant and invisible on dark skin tones. It also uses Zinc PCA for intelligent sebum regulation, making it suitable for oily and acne-prone Indian skin.

No. All Barekyne formulations use climate-stable active ingredients specifically designed for India's conditions. For example, we use Ethyl Ascorbic Acid (not L-Ascorbic Acid) because it resists heat and humidity degradation. Standard storage at room temperature away from direct sunlight is sufficient for all 5 products.

All Barekyne formulations are engineered specifically for melanin-rich Indian skin (Fitzpatrick Scale IV-VI) in high-UV, high-humidity, high-pollution conditions. They address the most common Indian skin concerns: hyperpigmentation, post-inflammatory hyperpigmentation (PIH), melasma, UV damage, TEWL, sebum overproduction, and acne. They are suitable for all Indian skin types — oily, dry, combination, and sensitive.

Yes. Barekyne has a dedicated Clinic & Doctor Supply program offering institutional bulk pricing, patient education materials, prescription pads, product stability documentation, and clinical summary reports. We supply dermatology clinics, aesthetic centers, hospitals, and medical practitioners directly. Visit barekyne.in/doctor-supply to apply.

The minimum order value for standard wholesale orders is INR 15,000. For exclusive district-level PCD franchise with complete monopoly rights, the initial inventory commitment starts at INR 50,000.

Barekyne differentiates on 5 key dimensions: (1) Focused 5-SKU clinical ecosystem vs. 200+ generic SKUs — zero dead stock risk. (2) Industry-leading net margins vs. 15-25% standard in general PCD. (3) 100% exclusive district-level monopoly vs. multi-distributor models. (4) WHO-GMP + CDSCO certified formulations vs. basic cosmetic manufacturing. (5) Products specifically engineered for Indian skin science (Fitzpatrick IV-VI) rather than Western formulas repackaged for India.

Barekyne has active franchise territory allocation in 15+ cities across India including Delhi, Mumbai, Bengaluru, Hyderabad, Chennai, Ahmedabad, Jaipur, Lucknow, Chandigarh, Kochi, Kolkata, Indore, Bhubaneswar, Mohali, and Pune. Visit barekyne.in/skincare-distributor to check territory availability in your city.